Thorne to Join P&G Health Care Portfolio

Today, P&G shared its intention to acquire Thorne, a leading science-driven wellness company known for its high-quality supplements and personalized health solutions backed by health care practitioners.

The acquisition would expand P&G Health Care's ability to meet growing consumer interest in self-care, prevention and personalized wellness — areas where trusted science, product quality and practitioner credibility increasingly matter.

"Thorne has built a highly trusted brand at the forefront of personalized health," said Paul Gama, Chief Executive Officer, Health Care. "Together, we see an opportunity to bring Thorne's science-backed wellness solutions to more consumers while continuing to build on the quality, credibility and innovation that have made the brand successful."

Thorne has earned a strong reputation with consumers, health care practitioners and professional partners through its commitment to scientific rigor, product quality and innovation. These strengths make Thorne a complementary fit with P&G's Health Care portfolio and our commitment to helping consumers improve everyday health and well-being.

The transaction is subject to customary closing conditions, including regulatory approvals. Closing is expected later in calendar year 2026.

Learn more about Thorne here.

Read the news release for more information.